Table 1: Ovarian Cancer – Pipeline Products by Stage of Development 16
Table 2: Ovarian Cancer – Pipeline Products by Territory 17
Table 3: Ovarian Cancer – Pipeline Products by Regulatory Path 18
Table 4: Ovarian Cancer – Pipeline Products by Estimated Approval Date 19
Table 5: Ovarian Cancer – Ongoing Clinical Trials 20
Table 6: Ovarian Cancer Companies – Pipeline Products by Stage of Development 21
Table 7: Ovarian Cancer – Pipeline Products by Stage of Development 25
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview 29
Table 9: IndiTreat – OVA – Product Status 29
Table 10: IndiTreat – OVA – Product Description 29
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 12: Companion Diagnostic Test – Ovarian Cancer – Product Status 30
Table 13: Companion Diagnostic Test – Ovarian Cancer – Product Description 30
Table 14: AB ANALITICA srl Pipeline Products & Ongoing Clinical Trials Overview 31
Table 15: Predictive Biomarker Kit – Ovarian Cancer – Product Status 31
Table 16: Predictive Biomarker Kit – Ovarian Cancer – Product Description 31
Table 17: Accudava Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 18: SEPEX – Product Status 32
Table 19: SEPEX – Product Description 32
Table 20: SETAX – Product Status 33
Table 21: SETAX – Product Description 33
Table 22: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 34
Table 23: ImmunoSEQ Dx – Ovarian Cancer – Product Status 34
Table 24: ImmunoSEQ Dx – Ovarian Cancer – Product Description 34
Table 25: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Table 26: ALM AADx Assay – Product Status 35
Table 27: ALM AADx Assay – Product Description 35
Table 28: Diagnostic Test – Ovarian Cancer – Product Status 36
Table 29: Diagnostic Test – Ovarian Cancer – Product Description 36
Table 30: DNA Damage Response Deficiency Assay – Ovarian Cancer – Product Status 36
Table 31: DNA Damage Response Deficiency Assay – Ovarian Cancer – Product Description 37
Table 32: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 33: Multiplex Ovarian Cancer Biomarker Assay – Product Status 38
Table 34: Multiplex Ovarian Cancer Biomarker Assay – Product Description 38
Table 35: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 39
Table 36: Cchek – Ovarian Cancer Confirmatory Test – Product Status 39
Table 37: Cchek – Ovarian Cancer Confirmatory Test – Product Description 39
Table 38: Cchek – Ovarian Cancer Recurrence Test – Product Status 40
Table 39: Cchek – Ovarian Cancer Recurrence Test – Product Description 40
Table 40: Cchek – Ovarian Cancer Screening Test – Product Status 40
Table 41: Cchek – Ovarian Cancer Screening Test – Product Description 41
Table 42: Cchek – Ovarian Cancer Treatment Monitoring Test – Product Status 41
Table 43: Cchek – Ovarian Cancer Treatment Monitoring Test – Product Description 41
Table 44: Anixa Diagnostics Corporation – Ongoing Clinical Trials Overview 42
Table 45: Cchek – Ovarian Cancer Screening Test – The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 43
Table 46: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 44
Table 47: TK 210 Assay – Ovarian Cancer – Product Status 44
Table 48: TK 210 Assay – Ovarian Cancer – Product Description 44
Table 49: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview 45
Table 50: Finger Stick Test – Ovarian Cancer – Product Status 45
Table 51: Finger Stick Test – Ovarian Cancer – Product Description 45
Table 52: Aspira Labs Pipeline Products & Ongoing Clinical Trials Overview 46
Table 53: OVA1 Plus Test – Product Status 46
Table 54: OVA1 Plus Test – Product Description 46
Table 55: Pelvic Mass Risk Assessment Biomarker Test – Product Status 47
Table 56: Pelvic Mass Risk Assessment Biomarker Test – Product Description 47
Table 57: Aspira Labs – Ongoing Clinical Trials Overview 48
Table 58: Pelvic Mass Risk Assessment Biomarker Test – A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women with Adnexal Mass and High-risk Germline Variants 49
Table 59: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 60: MMD ELISA Test – Ovarian Cancer – Product Status 50
Table 61: MMD ELISA Test – Ovarian Cancer – Product Description 50
Table 62: MMD QPCR Test – Ovarian cancer – Product Status 51
Table 63: MMD QPCR Test – Ovarian cancer – Product Description 51
Table 64: Ovarian Cancer Screening Test – Product Status 51
Table 65: Ovarian Cancer Screening Test – Product Description 52
Table 66: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 67: OvaDx – Product Status 53
Table 68: OvaDx – Product Description 53
Table 69: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54
Table 70: Diagnostic Test – Ovarian Cancer – Product Status 54
Table 71: Diagnostic Test – Ovarian Cancer – Product Description 54
Table 72: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 73: BARD1 Ovarian Cancer Test – Product Status 55
Table 74: BARD1 Ovarian Cancer Test – Product Description 55
Table 75: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 56
Table 76: Diagnostic Test – Ovarian Cancer – Product Status 56
Table 77: Diagnostic Test – Ovarian Cancer – Product Description 56
Table 78: BioFluidica Microtechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 57
Table 79: Circulating Tumor Cells Screening Assay – Ovarian Cancer – Product Status 57
Table 80: Circulating Tumor Cells Screening Assay – Ovarian Cancer – Product Description 57
Table 81: Bioindustry Park Silvano Fumero SpA Pipeline Products & Ongoing Clinical Trials Overview 58
Table 82: Diagnostic Kit – Ovarian Cancer – Product Status 58
Table 83: Diagnostic Kit – Ovarian Cancer – Product Description 58
Table 84: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 59
Table 85: Diagnostic Test – Ovarian Cancer – Product Status 59
Table 86: Diagnostic Test – Ovarian Cancer – Product Description 59
Table 87: Captis Biotechnology Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 88: Diagnostic Test – Ovarian Cancer – Product Status 60
Table 89: Diagnostic Test – Ovarian Cancer – Product Description 60
Table 90: Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 91: CELsignia Test – Ovarian Cancer – Product Status 61
Table 92: CELsignia Test – Ovarian Cancer – Product Description 61
Table 93: Celula Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 94: Diagnostic Test – Ovarian Cancer – Product Status 62
Table 95: Diagnostic Test – Ovarian Cancer – Product Description 62
Table 96: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 97: Nanotrap Ovarian Cancer Biomarker Test – Product Status 63
Table 98: Nanotrap Ovarian Cancer Biomarker Test – Product Description 63
Table 99: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 100: Diagnostic Test – Ovarian Cancer – Product Status 64
Table 101: Diagnostic Test – Ovarian Cancer – Product Description 64
Table 102: Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 103: Ovatax – Product Status 65
Table 104: Ovatax – Product Description 65
Table 105: ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 66
Table 106: Prognostic Assay – Ovarian Cancer – Product Status 66
Table 107: Prognostic Assay – Ovarian Cancer – Product Description 66
Table 108: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 109: Blood-Based Diagnostic Test – Ovarian Cancer – Product Status 67
Table 110: Blood-Based Diagnostic Test – Ovarian Cancer – Product Description 67
Table 111: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 112: Ovarian Cancer Diagnostic Panel – Product Status 68
Table 113: Ovarian Cancer Diagnostic Panel – Product Description 68
Table 114: Dana-Farber Cancer Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 115: Biomarker Assay – Ovarian Carcinoma – Product Status 69
Table 116: Biomarker Assay – Ovarian Carcinoma – Product Description 69
Table 117: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 118: B7-H4 Assay – Product Status 70
Table 119: B7-H4 Assay – Product Description 70
Table 120: DcR3 (DD-C248) Assay – Product Status 71
Table 121: DcR3 (DD-C248) Assay – Product Description 71
Table 122: MIC-1 (DD-X065) Assay – Product Status 71
Table 123: MIC-1 (DD-X065) Assay – Product Description 72
Table 124: Spondin-2 (DD-P108) Assay – Product Status 72
Table 125: Spondin-2 (DD-P108) Assay – Product Description 72
Table 126: Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview 73
Table 127: OpsisDx Test – Ovarian Cancer – Product Status 73
Table 128: OpsisDx Test – Ovarian Cancer – Product Description 73
Table 129: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74
Table 130: Octava Test – Ovarian Cancer – Product Status 74
Table 131: Octava Test – Ovarian Cancer – Product Description 74
Table 132: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 75
Table 133: Liquid Biopsy Test – Ovarian Cancer – Product Status 75
Table 134: Liquid Biopsy Test – Ovarian Cancer – Product Description 75
Table 135: Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview 76
Table 136: miRNA test – Ovarian Cancer – Product Status 76
Table 137: miRNA test – Ovarian Cancer – Product Description 76
Table 138: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 77
Table 139: EXOTEST Ovarian Cancer – Product Status 77
Table 140: EXOTEST Ovarian Cancer – Product Description 77
Table 141: Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
Table 142: Diagnostic Test – Ovarian Cancer – Product Status 78
Table 143: Diagnostic Test – Ovarian Cancer – Product Description 78
Table 144: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 79
Table 145: PTPL1 Based Prognostic Assay – Ovarian Cancer – Product Status 79
Table 146: PTPL1 Based Prognostic Assay – Ovarian Cancer – Product Description 79
Table 147: Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview 80
Table 148: IMAB027 Companion Diagnostic Test – Product Status 80
Table 149: IMAB027 Companion Diagnostic Test – Product Description 80
Table 150: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 81
Table 151: Mass Spectrometry Based Ovarian Cancer Test – Product Status 81
Table 152: Mass Spectrometry Based Ovarian Cancer Test – Product Description 81
Table 153: Gina-Life Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
Table 154: Biomarker Test – Ovarian Cancer – Product Status 82
Table 155: Biomarker Test – Ovarian Cancer – Product Description 82
Table 156: GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 157: Diagnostic Assay – Ovarian Cancer – Product Status 83
Table 158: Diagnostic Assay – Ovarian Cancer – Product Description 83
Table 159: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 84
Table 160: Diagnostic Assay – Ovarian Cancer – Product Status 84
Table 161: Diagnostic Assay – Ovarian Cancer – Product Description 84
Table 162: HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Table 163: ImmunoSignature Test – Ovarian Cancer – Product Status 85
Table 164: ImmunoSignature Test – Ovarian Cancer – Product Description 85
Table 165: Hide and Seq Pipeline Products & Ongoing Clinical Trials Overview 86
Table 166: Predictive Assay – Ovarian Cancer – Product Status 86
Table 167: Predictive Assay – Ovarian Cancer – Product Description 86
Table 168: Hudson Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 87
Table 169: Active Ratio Test – Product Status 87
Table 170: Active Ratio Test – Product Description 87
Table 171: Ikonisys Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 172: oncoFISH ovarian – Product Status 88
Table 173: oncoFISH ovarian – Product Description 88
Table 174: INEX Innovate Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
Table 175: Xena – Product Status 89
Table 176: Xena – Product Description 89
Table 177: InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview 90
Table 178: OncoVue Ovarian – Product Status 90
Table 179: OncoVue Ovarian – Product Description 90
Table 180: InterVenn BioSciences Pipeline Products & Ongoing Clinical Trials Overview 91
Table 181: Blood-Based Diagnostic Test – Ovarian Cancer – Product Status 91
Table 182: Blood-Based Diagnostic Test – Ovarian Cancer – Product Description 91
Table 183: InterVenn BioSciences – Ongoing Clinical Trials Overview 92
Table 184: Blood-Based Diagnostic Test – Ovarian Cancer – Clinical Validation of the InterVenn Ovarian Cancer Liquid Biopsy (VOCAL) 93
Table 185: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 94
Table 186: Biomarker Assay – Ovarian Cancer Chemoresistance – Product Status 94
Table 187: Biomarker Assay – Ovarian Cancer Chemoresistance – Product Description 94
Table 188: Blood Test – Rare Cancer Proteins – Product Status 95
Table 189: Blood Test – Rare Cancer Proteins – Product Description 95
Table 190: Methylation Based Biomarker Assay – Ovarian Cancer – Product Status 95
Table 191: Methylation Based Biomarker Assay – Ovarian Cancer – Product Description 96
Table 192: Multivariate Index Assay – Ovarian Cancer – Product Status 96
Table 193: Multivariate Index Assay – Ovarian Cancer – Product Description 96
Table 194: Protein Biomarker Diagnostic Assay – Ovarian Cancer Chemoresistance – Product Status 97
Table 195: Protein Biomarker Diagnostic Assay – Ovarian Cancer Chemoresistance – Product Description 97
Table 196: KIYATEC Inc Pipeline Products & Ongoing Clinical Trials Overview 98
Table 197: Ovarian Cancer Dx – Product Status 98
Table 198: Ovarian Cancer Dx – Product Description 98
Table 199: Lab Discoveries Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
Table 200: Diagnostic Test – Ovarian Cancer – Product Status 99
Table 201: Diagnostic Test – Ovarian Cancer – Product Description 99
Table 202: Laboratorios SALVAT SA Pipeline Products & Ongoing Clinical Trials Overview 100
Table 203: Diagnostic Kit – Ovarian Cancer – Product Status 100
Table 204: Diagnostic Kit – Ovarian Cancer – Product Description 100
Table 205: Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 101
Table 206: Ovarian Cancer Remission pT Test – Product Status 101
Table 207: Ovarian Cancer Remission pT Test – Product Description 101
Table 208: MabCure Inc Pipeline Products & Ongoing Clinical Trials Overview 102
Table 209: Diagnostic Test – Ovarian Cancer 1 – Product Status 102
Table 210: Diagnostic Test – Ovarian Cancer 1 – Product Description 102
Table 211: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 103
Table 212: Biomarker Test – Ovarian Cancer – Product Status 103
Table 213: Biomarker Test – Ovarian Cancer – Product Description 103
Table 214: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 104
Table 215: Ovarian Mitomic Test – Product Status 104
Table 216: Ovarian Mitomic Test – Product Description 104
Table 217: Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 105
Table 218: Diagnostic Test – Ovarian Cancer – Product Status 105
Table 219: Diagnostic Test – Ovarian Cancer – Product Description 105
Table 220: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 106
Table 221: Immunoassay – Ovarian Cancer – Product Status 106
Table 222: Immunoassay – Ovarian Cancer – Product Description 106
Table 223: MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 107
Table 224: Diagnostic Test – Ovarian Cancer – Product Status 107
Table 225: Diagnostic Test – Ovarian Cancer – Product Description 107
Table 226: Nagoya University Pipeline Products & Ongoing Clinical Trials Overview 108
Table 227: Biomarker Test – Primary Ovarian Insufficiency – Product Status 108
Table 228: Biomarker Test – Primary Ovarian Insufficiency – Product Description 108
Table 229: Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview 109
Table 230: ClarityDX Ovarian – Product Status 109
Table 231: ClarityDX Ovarian – Product Description 109
Table 232: Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 110
Table 233: NBT Diagnostic Test – Ovarian Cancer – Product Status 110
Table 234: NBT Diagnostic Test – Ovarian Cancer – Product Description 110
Table 235: Olink Proteomics AB Pipeline Products & Ongoing Clinical Trials Overview 111
Table 236: Blood Test – Ovarian Cancer – Product Status 111
Table 237: Blood Test – Ovarian Cancer – Product Description 111
Table 238: Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 112
Table 239: Prognostic Test – Ovarian Cancer – Product Status 112
Table 240: Prognostic Test – Ovarian Cancer – Product Description 112
Table 241: Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
Table 242: Oncgnostics Diagnostic Test – Ovarian Cancer – Product Status 113
Table 243: Oncgnostics Diagnostic Test – Ovarian Cancer – Product Description 113
Table 244: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 114
Table 245: EarlyCDT – Ovarian Cancer – Product Status 114
Table 246: EarlyCDT – Ovarian Cancer – Product Description 114
Table 247: Oncology Venture U.S. Inc Pipeline Products & Ongoing Clinical Trials Overview 115
Table 248: 2X-131 Companion Diagnostic Assay – Product Status 115
Table 249: 2X-131 Companion Diagnostic Assay – Product Description 115
Table 250: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 116
Table 251: Diagnostic Test – Ovarian Cancer – Product Status 116
Table 252: Diagnostic Test – Ovarian Cancer – Product Description 116
Table 253: OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 117
Table 254: OV Sera Dx – Product Status 117
Table 255: OV Sera Dx – Product Description 117
Table 256: Peregrine Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
Table 257: Exosome Based Blood Test – Ovarian Cancer – Product Status 118
Table 258: Exosome Based Blood Test – Ovarian Cancer – Product Description 118
Table 259: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 119
Table 260: Saliva Test – Ovarian Cancer – Product Status 119
Table 261: Saliva Test – Ovarian Cancer – Product Description 119
Table 262: Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 120
Table 263: Diagnostic Assay – Ovarian Cancer – Product Status 120
Table 264: Diagnostic Assay – Ovarian Cancer – Product Description 120
Table 265: Preora Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 121
Table 266: Cancer Risk Stratification Test – Ovarian Cancer – Product Status 121
Table 267: Cancer Risk Stratification Test – Ovarian Cancer – Product Description 121
Table 268: Princess Margaret Cancer Centre Pipeline Products & Ongoing Clinical Trials Overview 122
Table 269: Clinical Screening Tool – Ovarian Cancer – Product Status 122
Table 270: Clinical Screening Tool – Ovarian Cancer – Product Description 122
Table 271: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 123
Table 272: Diagnostic Assay – Ovarian Cancer – Product Status 123
Table 273: Diagnostic Assay – Ovarian Cancer – Product Description 123
Table 274: Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124
Table 275: Proteomika Biomarker Test – Ovarian Cancer – Product Status 124
Table 276: Proteomika Biomarker Test – Ovarian Cancer – Product Description 124
Table 277: Provista Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 125
Table 278: Videssa Ovarian – Product Status 125
Table 279: Videssa Ovarian – Product Description 125
Table 280: Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview 126
Table 281: Blood Test – Epithelial Ovarian Cancer – Product Status 126
Table 282: Blood Test – Epithelial Ovarian Cancer – Product Description 126
Table 283: Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 127
Table 284: microRNA Test – Ovarian Cancer – Product Status 127
Table 285: microRNA Test – Ovarian Cancer – Product Description 127
Table 286: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
Table 287: CL-2000i – HE4 Test – Product Status 128
Table 288: CL-2000i – HE4 Test – Product Description 128
Table 289: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 129
Table 290: SomaSignal Test – Ovarian Cancer – Product Status 129
Table 291: SomaSignal Test – Ovarian Cancer – Product Description 129
Table 292: Soricimed Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 130
Table 293: Diagnostic SOR-D01 Assay – Ovarian Cancer – Product Status 130
Table 294: Diagnostic SOR-D01 Assay – Ovarian Cancer – Product Description 130
Table 295: Diagnostic SOR-D02 Assay – Ovarian Cancer – Product Status 131
Table 296: Diagnostic SOR-D02 Assay – Ovarian Cancer – Product Description 131
Table 297: Stage I Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 132
Table 298: O-TAB Test – Product Status 132
Table 299: O-TAB Test – Product Description 132
Table 300: StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 133
Table 301: Biomarker Diagnostic Test – Ovarian Cancer – Product Status 133
Table 302: Biomarker Diagnostic Test – Ovarian Cancer – Product Description 133
Table 303: SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview 134
Table 304: Diagnostic Test – Ovarian Cancer – Product Status 134
Table 305: Diagnostic Test – Ovarian Cancer – Product Description 134
Table 306: Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 135
Table 307: HE4 Detection Kit – Product Status 135
Table 308: HE4 Detection Kit – Product Description 135
Table 309: Target Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 136
Table 310: Isonostic Assay – Ovarian Cancer – Product Status 136
Table 311: Isonostic Assay – Ovarian Cancer – Product Description 136
Table 312: Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
Table 313: Diagnostic Assay – Ovarian Cancer – Product Status 137
Table 314: Diagnostic Assay – Ovarian Cancer – Product Description 137
Table 315: The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 138
Table 316: Nanoscale Blood Test – Ovarian Cancer – Product Status 138
Table 317: Nanoscale Blood Test – Ovarian Cancer – Product Description 138
Table 318: Tradewind BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 139
Table 319: Companion Diagnostic Assay – Ovarian Cancer – Product Status 139
Table 320: Companion Diagnostic Assay – Ovarian Cancer – Product Description 139
Table 321: Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 140
Table 322: PolyPEPI 1212 CDx – Product Status 140
Table 323: PolyPEPI 1212 CDx – Product Description 140
Table 324: University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 141
Table 325: Glycan Test – Ovarian Cancer – Product Status 141
Table 326: Glycan Test – Ovarian Cancer – Product Description 141
Table 327: Luminex Assay – Product Status 142
Table 328: Luminex Assay – Product Description 142
Table 329: University of Arkansas for Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 143
Table 330: Diagnostic Assay – Epithelial Ovarian Cancer – Product Status 143
Table 331: Diagnostic Assay – Epithelial Ovarian Cancer – Product Description 143
Table 332: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 144
Table 333: Diagnostic Test – Ovarian Cancer – Product Status 144
Table 334: Diagnostic Test – Ovarian Cancer – Product Description 144
Table 335: University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 145
Table 336: Diagnostic Test – Ovarian Cancer – Product Status 145
Table 337: Diagnostic Test – Ovarian Cancer – Product Description 145
Table 338: University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 146
Table 339: Serum Biomarker Test – Ovarian Cancer – Product Status 146
Table 340: Serum Biomarker Test – Ovarian Cancer – Product Description 146
Table 341: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 147
Table 342: Biomarker Test – Ovarian Cancer – Product Status 147
Table 343: Biomarker Test – Ovarian Cancer – Product Description 147
Table 344: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 148
Table 345: Biomarker Test – Ovarian Cancer – Product Status 148
Table 346: Biomarker Test – Ovarian Cancer – Product Description 148
Table 347: HMGA2 Based Diagnostic Assay – Ovarian Cancer – Product Status 149
Table 348: HMGA2 Based Diagnostic Assay – Ovarian Cancer – Product Description 149
Table 349: Lysophospholipids Biomarker Assay – Ovarian Cancer – Product Status 149
Table 350: Lysophospholipids Biomarker Assay – Ovarian Cancer – Product Description 150
Table 351: University of Texas MD Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 151
Table 352: Diagnostic Assay – Ovarian Cancer – Product Status 151
Table 353: Diagnostic Assay – Ovarian Cancer – Product Description 151
Table 354: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 152
Table 355: Blood-Based Biomarker – Ovarian Cancer – Product Status 152
Table 356: Blood-Based Biomarker – Ovarian Cancer – Product Description 152
Table 357: Vermillion Inc Pipeline Products & Ongoing Clinical Trials Overview 153
Table 358: OvaCheck 2 – Product Status 153
Table 359: OvaCheck 2 – Product Description 153
Table 360: Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 154
Table 361: Diagnostic Assay – Ovarian Cancer – Product Status 154
Table 362: Diagnostic Assay – Ovarian Cancer – Product Description 154
Table 363: Wistar Institute Pipeline Products & Ongoing Clinical Trials Overview 155
Table 364: Blood Biomarker Test – Epithelial Ovarian Cancer – Product Status 155
Table 365: Blood Biomarker Test – Epithelial Ovarian Cancer – Product Description 155
Table 366: Yale University Pipeline Products & Ongoing Clinical Trials Overview 156
Table 367: Diagnostic Assay – Ovarian Cancer – Product Status 156
Table 368: Diagnostic Assay – Ovarian Cancer – Product Description 156
Table 369: Targeted Ovarian Cancer Proteome Assay – Product Status 157
Table 370: Targeted Ovarian Cancer Proteome Assay – Product Description 157
Table 371: ZORA Biosciences Oy Pipeline Products & Ongoing Clinical Trials Overview 158
Table 372: Ovarian Cancer Diagnostic Test – Product Status 158
Table 373: Ovarian Cancer Diagnostic Test – Product Description 158
